More than 650 scientists and clinicians from around the world will gather in Phoenix next week to share these and many other novel findings at the second annual American Association for Cancer Research (AACR) International Conference on Frontiers in Cancer Prevention Research.
"Over the past five years there have been significant advances in our understanding of the signaling pathways responsible for the development of both pre-invasive and invasive cancers," said Raymond N. DuBois, Ph.D., M.D., meeting chairperson and Professor of Medicine and Cell Biology and Director, Division of Gastroenterology, Vanderbilt University Medical Center, Nashville, Tenn.
"This meeting will provide a venue for discussion of our current strategies for cancer prevention and for a critical evaluation of exciting new opportunities to reduce the high burden of cancer on our society by using better diagnostics, predictive markers and personalized medicine," he added.
A sea change in the war on cancer is quietly under way in the laboratories of medical centers, research hospitals, universities, government health agencies and pharmaceutical companies globally. The burgeoning field of cancer prevention